HIV Access

Abbott is dedicated to providing worldwide access to its HIV medications and to supporting those affected by the disease. Learn more about our ongoing efforts.

Press Release

AfdrukkenAfdrukken
(description)

Paragraaf titel

Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Etiam ut purus. Aliquam egestas neque a enim. Nulla ullamcorper quam sit amet urna. Duis vehicula libero ac felis. Vivamus ullamcorper, nisl non pretium pretium, arcu massa rhoncus mauris, et varius velit risus at eros.

Nieuws

Abbott's Preclinical Oncology Pipeline May Help Advance Fight Against Cancer
Robust preclinical data has shown that several compounds in Abbott’s oncology pipeline may interfere with the vital processes of a cancer cell. Lees meer  
Abbott Opens New Biotechnology Manufacturing Facility in Puerto Rico
Abbott has officially opened Abbott Biotechnology Limited – the new, state-of-the-art biologics manufacturing facility in Puerto Rico that will support the long-term supply of the leading biologic agent, HUMIRA®. Lees meer  
Making Sense of Monoclonal Antibodies
As highly targeted disease fighters, therapeutic monoclonal antibodies (mAbs) are revolutionizing the treatment of many illnesses including rheumatoid arthritis. Lees meer  
Meer nieuws...